课题基金 / 基金详情

Molecular mechanisms of organ regeneration and homeoslasis by injurin/HGF system.

Molecular mechanisms of organ regeneration and homeoslasis by injurin/HGF system.
Injurin/HGF 系统器官再生和稳态的分子机制。
批准号:
05404080
负责人:
NAKAMURA Toshikazu
金额:
$20.29万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

NAKAMURA Toshikazu的其他基金

相似基金

相关文献

中文摘要
翻译
(1)HGF作为有机营养因子的作用:重组HGF可抑制慢性肝损伤所致的肝纤维化、肝硬变和脂肪肝的发生。我们发现HGF在肾和肺的再生中起着肾营养因子和肺营养因子的作用。HGF很可能成为治疗各种器官疾病的新药物,包括肝纤维化/肝硬变、急性肾功能衰竭和肺纤维化。(2)HGF作为一种神经营养因子:HGF促进体外培养的海马神经元存活。重要的是,输注的重组HGF能显著防止大鼠缺血损伤引起的神经元死亡。(3)HGF作为上皮-间充质相互作用的中介:上皮-间充质相互作用是器官发生的关键组织相互作用。HGF在间质组织中表达,而c-Met/HGF受体在肝、肾、肺牙、肢体等发育过程中的上皮组织中表达。HGF作为间质衍生因子支持肝、肾、肺、牙齿、乳腺等多种器官的器官发生。(4)HGF是肿瘤-间质相互作用:肿瘤细胞的恶性表型通过与宿主基质细胞的相互作用来调节。我们发现各种肿瘤细胞产生HGF诱导物(损伤素),间质来源的HGF促进肿瘤细胞的侵袭。肿瘤细胞与宿主基质细胞之间的物质相互作用介导肿瘤-间质相互作用。(5)肝细胞生长因子诱导物的鉴定:我们从肺组织提取液中分离纯化了S等人肺组织中的肝细胞生长因子,发现它们是IL-1、PDGF和bFGF。相反,我们发现转化生长因子-β和糖皮质激素是HGF表达的负调节因子。
英文摘要
(1) Roles of HGF as an organotrophic factor : Recombinant HGF suppressed the onset of liver fibrosis/cirrhosis and fatty liver caused by chronic hepatic injury. We found that HGF functions as renotrophic and pulmotrophic factor for regeneration of the kidney and lung. HGF may well become a new therapeutic drug for the treatment of various organ diseases, including liver fibrosis/cirrhosis, acute renal failure, and lung fibrosis.(2) HGF as a neurotrophic factor : HGF stimulated survival of hippocampal neurons in vitro. Importantly, the infused recombinant HGF markedly prevented neuronal death caused by ischemic injury in rats.(3) HGF as a mediator in epithelial-mesenchymal interactions : Epithelial-mesenchymal interaction is a critical tissue interaction for organogenesis. HGF is expressed in mesenchymal tissue, while c-Met/HGF receptor in epithelial tissue during development of the liver, kidney, lung tooth, limb, etc. HGF supports organogenesis of various organs, such as the liver, kidney, lung, tooth, mammary gland, as a mesenchymal-derived factor.(4) HGF is tumor-stromal interactions : Malignant phenotypes of tumor cells are regulated through their interactions with host stromal cells. We found that various tumor cells produce HGF-inducer (injurin) and stromal-derived HGF enhanced the invation of tumor cells. Matual interaction between tumor cells and host stromal cells mediate tumor-stromal interactions.(5) Identification of injurin (HGF-inducer) : We purified injurin (s) from lung tissue extract and found that these are IL-1, PDGF,and bFGF.Likewise, we identified tumor-derived injurins as IL-1, PDGF,and bFGF.But mouse mammary tumor cells produced novel HGF-inducer. In contrast, we found that TGF-beta and glucocorticoids are negative regulator of HGF expression.
期刊论文(353)
专著(0)
科研奖励(0)
会议论文
G.Shiota: "Hepatocyte growth factor accelerates liver regeneration and causes a hepatoproliferative disorder in transgenic mice." Hepatology. (in press). (1994)
G.Shiota:“肝细胞生长因子可加速肝脏再生,并导致转基因小鼠出现肝增殖性疾病。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
G.Shiota: "Autocrine stimulation of glioblastoma cells resulting from expression of c-met and the met-ligand(Scatter factor/Hepatocyte growth factor)." Oncogene. (in press). (1994)
G.Shiota:“c-met 和 met-配体(分散因子/肝细胞生长因子)的表达导致胶质母细胞瘤细胞的自分泌刺激。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
J.Wojta: "Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells in culture." Blood. 84. 151-157 (1994)
J.Wojta:“肝细胞生长因子可刺激培养的 HepG2 细胞中 1 型纤溶酶原激活剂抑制剂和组织因子的表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 298 条
    DISTANCE MEASUREMENTS OF FIBROUS PRION PROTEINS BY PULSE ESR SPECTROSCOPY
    • 批准号:
      24654112
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    Analysis of molecular mechanisms that reciprocally regulate growth and differentiation of mature hepatocytes
    • 批准号:
      21390079
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2009
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    Investigation of Spin Dynamics and Development of Devices for Low-Dimensional Electronic Phases
    • 批准号:
      20340095
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.49万
    • 财政年份:
      2008
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    Molecular Mechanisms of Tissue Regeneration through the Conversion of HGF Receptor Signaling in Response of Injury
    • 批准号:
      18390087
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.57万
    • 财政年份:
      2006
    • 负责人:
      NAKAMURA Toshikazu
    • 依托单位:
    国内基金
    海外基金
    金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
    • 批准号:
      2026JJ81256
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李弘德
    • 依托单位:
    复方香巴戟膏介导的NO/HGF/c-met通路活化卫星细胞促进损伤后肌肉组织再生
    • 批准号:
      2025JJ70694
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      丁轩
    • 依托单位:
    安罗替尼通过调控HGF/c-MET信号通路与自噬相互作用促进人脑胶质瘤细胞凋亡的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      刘细帮
    • 依托单位:
    新型靶向c-MET/EGFR小分子抑制剂ZP-32克服EGFR TKI MET扩增耐药的非小细胞肺癌脑转作用及机制研究
    • 批准号:
      2025JJ70229
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      刘兰
    • 依托单位: